107 related articles for article (PubMed ID: 7522018)
1. Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss. Results of a double-blind randomized clinical trial.
Kallis P; Tooze JA; Talbot S; Cowans D; Bevan DH; Treasure T
Eur J Cardiothorac Surg; 1994; 8(6):315-22; discussion 22-3. PubMed ID: 7522018
[TBL] [Abstract][Full Text] [Related]
2. Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol).
Lu H; Soria C; Commin PL; Soria J; Piwnica A; Schumann F; Regnier O; Legrand Y; Caen JP
Thromb Haemost; 1991 Dec; 66(6):633-7. PubMed ID: 1724577
[TBL] [Abstract][Full Text] [Related]
3. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets.
Orchard MA; Goodchild CS; Prentice CR; Davies JA; Benoit SE; Creighton-Kemsford LJ; Gaffney PJ; Michelson AD
Br J Haematol; 1993 Nov; 85(3):533-41. PubMed ID: 7510990
[TBL] [Abstract][Full Text] [Related]
4. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
[TBL] [Abstract][Full Text] [Related]
5. Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin.
Basora M; Gomar C; Escolar G; Pacheco M; Fita G; Rodriguez E; Ordinas A
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):382-7. PubMed ID: 10468248
[TBL] [Abstract][Full Text] [Related]
6. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study.
García-Huete L; Domenech P; Sabaté A; Martínez-Brotons F; Jaurrieta E; Figueras J
Hepatology; 1997 Nov; 26(5):1143-8. PubMed ID: 9362354
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
[TBL] [Abstract][Full Text] [Related]
8. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
[TBL] [Abstract][Full Text] [Related]
9. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss.
Grosse H; Lobbes W; Frambach M; von Broen O; Ringe B; Barthels M
Thromb Res; 1991 Aug; 63(3):287-97. PubMed ID: 1720262
[TBL] [Abstract][Full Text] [Related]
10. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery.
Rocha E; Hidalgo F; Llorens R; Melero JM; Arroyo JL; Páramo JA
Circulation; 1994 Aug; 90(2):921-7. PubMed ID: 7519132
[TBL] [Abstract][Full Text] [Related]
11. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
[TBL] [Abstract][Full Text] [Related]
12. Is there a phase of hypercoagulability when aprotinin is used in cardiac surgery?
Feindt P; Seyfert U; Volkmer I; Huwer H; Kalweit G; Gams E
Eur J Cardiothorac Surg; 1994; 8(6):308-13; discussion 313-4. PubMed ID: 7522017
[TBL] [Abstract][Full Text] [Related]
13. Platelet preservation during cardiopulmonary bypass with aprotinin.
Wildevuur CR; Eijsman L; Roozendaal KJ; Harder MP; Chang M; van Oeveren W
Eur J Cardiothorac Surg; 1989; 3(6):533-7; discussion 537-8. PubMed ID: 2483979
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin restores the adhesive capacity of dysfunctional platelets.
Bradfield JF; Bode AP
Thromb Res; 2003 Feb; 109(4):181-8. PubMed ID: 12757772
[TBL] [Abstract][Full Text] [Related]
15. The antithrombotic effect of dextran-40 in man is due to enhanced fibrinolysis in vivo.
Jones CI; Payne DA; Hayes PD; Naylor AR; Bell PR; Thompson MM; Goodall AH
J Vasc Surg; 2008 Sep; 48(3):715-22. PubMed ID: 18572351
[TBL] [Abstract][Full Text] [Related]
16. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
Jia XQ; Dong CM; Qin J; Zhang L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapy.
Kuepper F; Dangas G; Mueller-Chorus A; Kulka PM; Zenz M; Wiebalck A
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):147-53. PubMed ID: 12632024
[TBL] [Abstract][Full Text] [Related]
18. Aprotinin versus placebo in major orthopedic surgery: a randomized, double-blinded, dose-ranging study.
Samama CM; Langeron O; Rosencher N; Capdevila X; Rouche P; Pegoix M; Bernière J; Coriat P
Anesth Analg; 2002 Aug; 95(2):287-93, table of contents. PubMed ID: 12145035
[TBL] [Abstract][Full Text] [Related]
19. Effects of half-dose aprotinin in off-pump coronary artery bypass grafting.
Wei M; Jian K; Guo Z; Li P; Han J; Cai Z; Tarkka M
World J Surg; 2006 Jun; 30(6):1108-14. PubMed ID: 16736344
[TBL] [Abstract][Full Text] [Related]
20. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
